HM

Holly Maloney Mcconnell

Managing Director at General Catalyst

San Francisco, California

Overview 

Holly Maloney McConnell is the Managing Director at General Catalyst, specializing in investing in health assurance. She has a strong background in private equity and entrepreneurship, with notable achievements including investments in companies like Maven Clinic and Capital Rx. McConnell's career highlights include serving on the boards of InStride Health and Fabric, and investing in a range of companies including Adonis, Ribbon Health, and SonderMind.

Work Experience 

  • Managing Director

    2017 - Current

    All things Health Assurance

General Catalyst partners with ambitious founders to drive resilience and applied AI from seed to growth.

  • Board Member

    2025

  • Board Member

    2024

  • Board Member

    2024

Fabric is an innovator in healthcare enablement software.

Raised $80,000,000.00 from Thrive Capital, Vast Ventures, BoxGroup, Atento Capital, General Catalyst, Google Ventures and Salesforce Ventures.

  • Board Member

    2022

Maven is a digital health platform that works with health plans and employers to offer virtual services for women’s and family health.

Raised $417,100,000.00 from Icon Ventures, General Catalyst, Dragoneer Investment Group, Sequoia Capital, Lux Capital, StepStone Group and Oak HC/FT.

  • Board Observer

    2022

Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.

Raised $252,960,628.00 from Prime Therapeutics.

  • Board Member

    2020

Transcarent is a provider of a healthcare platform that facilitates improved outcomes and cost-effective decisions.

Raised $424,000,000.00 from 7wire Ventures, Human Capital, Memorial Hermann Health System, General Catalyst, Leaps by Bayer, Alta Partners, Ally Bridge Group, Kinnevik, Geodesic Capital and Threshold.

  • Board Member

    2022

Equip Health provides a virtual eating disorder treatment program designed to assist families recover from eating disorders at home.

Raised $109,689,935.00 from Trybe Ventures, Alex Morgan, General Catalyst, TCG, Tiger Global Management, .406 Ventures, Stripes, F-Prime Capital, Optum Ventures and Katie Couric Media.

  • Board Member

    2024

InStride Health provides evidence-based OCD and anxiety treatment to keep kids and teenagers engaged along the way.

Raised $56,000,000.00 from .406 Ventures, General Catalyst, Mass General Brigham Ventures, Hopelab and Valtruis.

  • Board Member

    2023

Articles About Holly

Relevant Websites